Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma
Status:
Withdrawn
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if pemetrexed is effective in the treatment of
primary central nervous system lymphoma (PCNSL) that has either worsened during treatment or
has returned after completing treatment.